Trial Outcomes & Findings for Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I (NCT NCT01256281)
NCT ID: NCT01256281
Last Updated: 2015-04-23
Results Overview
Pain score in legs at 2-4 hours after intervention will be the primary outcome. Data analysis not done.
Recruitment status
TERMINATED
Study phase
PHASE1
Target enrollment
2 participants
Primary outcome timeframe
2-4 hours after intervention
Results posted on
2015-04-23
Participant Flow
Participant milestones
| Measure |
Femoral Nerve Block
Patients enrolled will receive ultrasound guided FNB in addition to standard care. If subjects are experiencing pain in both lower extremities, both extremities will be blocked; if subjects are experiencing pain in one lower extremity, only the affected extremity will be blocked.
|
|---|---|
|
Overall Study
STARTED
|
2
|
|
Overall Study
COMPLETED
|
2
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
Baseline characteristics by cohort
| Measure |
Femoral Nerve Block
n=2 Participants
Patients enrolled will receive ultrasound guided FNB in addition to standard care. If subjects are experiencing pain in both lower extremities, both extremities will be blocked; if subjects are experiencing pain in one lower extremity, only the affected extremity will be blocked.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
2 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2-4 hours after interventionPain score in legs at 2-4 hours after intervention will be the primary outcome. Data analysis not done.
Outcome measures
Outcome data not reported
Adverse Events
Femoral Nerve Block
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Jeffrey Glassberg
Icahn School of Medicine at Mount Sinai
Phone: (212) 824-8056
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place